Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$37.43

-0.36 (-0.95%)

, INVA

Innoviva

$10.21

-0.13 (-1.26%)

05:30
12/02/16
12/02
05:30
12/02/16
05:30

GSK, Innoviva announce Relvar Ellipta approved in Japan for patients with COPD

GlaxoSmithKline plc (GSK) and Innoviva (INVA) announced that the Japanese Ministry of Health, Labour and Welfare has approved Relvar Ellipta for the relief of various symptoms with chronic obstructive pulmonary disease.

GSK

GlaxoSmithKline

$37.43

-0.36 (-0.95%)

INVA

Innoviva

$10.21

-0.13 (-1.26%)

GSK GlaxoSmithKline
$37.43

-0.36 (-0.95%)

09/23/16
09/23/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Morgan Stanley analyst Brian Nowak initiated Activision Blizzard (ATVI) and Electronic Arts (EA), both with Overweight ratings. The analyst is bullish on the digital gaming shift away from "units sold" to a business model based on users, engagement, and digital monetization. He sees digital in-game offerings resulting in recurring and growth user bases, increased per-game engagement, and further monetization opportunities. 2. AstraZeneca (AZN) and GlaxoSmithKline (GSK) both initiated with Overweight ratings by Piper Jaffray analyst Richard Purkiss. 3. Achillion (ACHN) initiated with an Outperform by Wedbush analyst Heather Behanna, who set a $13 price target on the shares. 4. Sysco (SYY) initiated with an Underweight at Barclays and $48 price target by analyst Karen Short. 5. Five Below (FIVE), Dollar Tree (DLTR) and Dollar General (DG) all initiated with Equal Weight ratings by Barclays analyst Karen Short. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/16
RBCM
10/03/16
NO CHANGE
Target $95
RBCM
Outperform
Gilead HIV franchise could see risk from competitor data, says RBC Capital
RBC Capital analyst Michael Yee said his conversations with doctors leads him to think two dolutegravir HIV "doublet" studies being conducted by GlaxoSmithKline (GSK) and ViiV Healthcare - Glaxo's joint venture with Pfizer (PFE) and Shionogi - are likely to work and present an underappreciated risk to Gilead's (GILD) HIV franchise. Talks with investors lead Yee to believe few are even aware of this risk and that the consensus view is underestimating the probability these non-inferiority trials will work. Arguing that the consensus view should factor in more conservative assumptions for Gilead's HIV business post 2018 due to this risk, Yee cut his price target on Gilead to $95 from $105, but keeps an Outperform rating on the shares.
10/06/16
PIPR
10/06/16
NO CHANGE
Target $46
PIPR
Overweight
Piper thinks Alnylam failure is positive for Ionis
Piper Jaffay analyst Joshua Schimmer thinks Alnylam Pharmaceuticals' (ALNY) "abrupt halt" of revusiran for TTR cardiomyopathy is likely a positive for Ionis Pharmaceuticals' (IONS) transthyretin program. The move "knocks out a competitive drug" while Ionis and GlaxoSmithKline (GSK) remain on their previously indicated timeline, Schimmer tells investors in a research note. The analyst at this point believes Alnylam's setback will be limited to revusiran and not read-through to other Gal-Nac programs or other TTR cardiomyopathy or polyneuropathy programs. He keeps an Overweight rating on Ionis with a $46 price target,
11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.
INVA Innoviva
$10.21

-0.13 (-1.26%)

10/31/16
COWN
10/31/16
UPGRADE
Target $15
COWN
Outperform
Innoviva upgraded to Outperform from Market Perform at Cowen
Cowen analyst Tyler Van Buren upgraded Innoviva to Outperform and raised its price target to $15 from $13 citing valuation discount and said the commercial prospects for Breo and Anoro remain stronger than ever heading into next year.

TODAY'S FREE FLY STORIES

GLOW

Glowpoint

$0.33

-0.0056 (-1.68%)

15:08
01/22/18
01/22
15:08
01/22/18
15:08
Hot Stocks
Breaking Hot Stocks news story on Glowpoint »

Glowpoint trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTT

inTEST

$8.84

-0.26 (-2.86%)

15:04
01/22/18
01/22
15:04
01/22/18
15:04
Initiation
inTEST initiated  »

inTEST initiated with $11…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEPT

Neptune Technologies

$3.05

0.14 (4.81%)

15:00
01/22/18
01/22
15:00
01/22/18
15:00
Options
New positions opened in Neptune Tech February puts and calls »

New positions opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
01/22/18
01/22
14:55
01/22/18
14:55
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

PTEN

Patterson-UTI

$24.48

0.6 (2.51%)

14:54
01/22/18
01/22
14:54
01/22/18
14:54
Periodicals
Patterson-UTI confirms responding to fire at Oklahoma rig, FOX23 says »

Patterson-UTI confirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

MRNS

Marinus Pharmaceuticals

$6.83

-0.05 (-0.73%)

14:50
01/22/18
01/22
14:50
01/22/18
14:50
Options
Notable call buying in Marinus Pharmaceuticals as shares see relative strength »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

, XLI

Industrial Select Sector SPDR

$79.45

-0.24 (-0.30%)

14:49
01/22/18
01/22
14:49
01/22/18
14:49
Technical Analysis
Technical Take: S&P 500 moves to new high, levels to watch »

The S&P 500 (SPX) has…

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

XLI

Industrial Select Sector SPDR

$79.45

-0.24 (-0.30%)

XLB

S&P Select Materials SPDR

$62.93

-0.35 (-0.55%)

XLY

Consumer Discretionary Sector SPDR

$106.28

0.6762 (0.64%)

XLE

Energy Select Sector SPDR

$77.78

1.4 (1.83%)

XLK

Technology Select Sector SPDR

$68.19

0.385 (0.57%)

SPY

SPDR S&P 500 ETF Trust

$281.59

1.181 (0.42%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 18

    Mar

CELG

Celgene

$102.65

0.93 (0.91%)

14:40
01/22/18
01/22
14:40
01/22/18
14:40
Options
Celgene calls outpace puts 3:1 as shares tick modestly higher »

Celgene calls outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

14:40
01/22/18
01/22
14:40
01/22/18
14:40
General news
Treasury Action: yields have reversed the earlier declines »

Treasury Action: yields…

GENC

Gencor Industries

14:30
01/22/18
01/22
14:30
01/22/18
14:30
Hot Stocks
Royce & Associates reports 7.37% passive stake in Gencor Industries »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPL

Buckeye Partners

$56.18

1.155 (2.10%)

14:30
01/22/18
01/22
14:30
01/22/18
14:30
Options
Bullish option flow in Buckeye Partners as shares rally »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Feb

CLVS

Clovis

$56.76

0.89 (1.59%)

14:25
01/22/18
01/22
14:25
01/22/18
14:25
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Feb

$NSD

NASDAQ Market Internals

14:17
01/22/18
01/22
14:17
01/22/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/22/18
01/22
14:16
01/22/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYBE

Cyberoptics

$17.15

0.45 (2.69%)

14:05
01/22/18
01/22
14:05
01/22/18
14:05
Hot Stocks
Royce & Associates reports 9.64% passive stake in Cyberoptics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$34.31

0.81 (2.42%)

14:05
01/22/18
01/22
14:05
01/22/18
14:05
Options
FMC Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CTB

Cooper Tire

$39.65

-0.7 (-1.73%)

14:04
01/22/18
01/22
14:04
01/22/18
14:04
Hot Stocks
Royce & Associates reports 5.14% passive stake in Cooper Tire »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTG

Computer Task Group

$5.09

0.12 (2.41%)

14:02
01/22/18
01/22
14:02
01/22/18
14:02
Hot Stocks
Breaking Hot Stocks news story on Computer Task Group »

Royce & Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$85.88

18.185 (26.87%)

14:01
01/22/18
01/22
14:01
01/22/18
14:01
Downgrade
Juno Therapeutics rating change  »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGR

Ingredion

$140.05

2.92 (2.13%)

13:47
01/22/18
01/22
13:47
01/22/18
13:47
Hot Stocks
Ingredion promotes Anthony DeLio to SVP, corporate strategy »

Ingredion Incorporated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

ADSK

Autodesk

$115.29

2.74 (2.43%)

13:45
01/22/18
01/22
13:45
01/22/18
13:45
Options
Autodesk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$47.41

-0.86 (-1.78%)

13:44
01/22/18
01/22
13:44
01/22/18
13:44
Hot Stocks
Breaking Hot Stocks news story on Globant »

JP Morgan Chase reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

NWSA

News Corp.

$17.22

0.21 (1.23%)

, NWS

News Corp

$17.55

0.15 (0.86%)

13:39
01/22/18
01/22
13:39
01/22/18
13:39
Hot Stocks
News Corp. chairman Murdoch makes case for carriage fee for trusted publishers »

News Corp. (NWSA) issued…

NWSA

News Corp.

$17.22

0.21 (1.23%)

NWS

News Corp

$17.55

0.15 (0.86%)

FB

Facebook

$181.29

1.49 (0.83%)

GOOG

Alphabet

$1,137.51

7.72 (0.68%)

GOOGL

Alphabet Class A

$1,143.50

7.53 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

  • 18

    Mar

W

Wayfair

$90.98

3.135 (3.57%)

13:35
01/22/18
01/22
13:35
01/22/18
13:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

13:35
01/22/18
01/22
13:35
01/22/18
13:35
General news
Treasury Action: yields rebounded towards highs »

Treasury Action: yields…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.